Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

ACP-104 in Acutely Psychotic Subjects With Schizophrenia

This study has been completed.
Information provided by:
ACADIA Pharmaceuticals Inc. Identifier:
First received: June 21, 2007
Last updated: February 22, 2008
Last verified: February 2008
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: February 2008 (Final data collection date for primary outcome measure)